A New Jersey drugmaker has voluntarily recalled thousands of bottles of a combination high blood pressure medication over concerns the product could be cross-contaminated with another drug, the Federal Drug Administration (FDA) said.
The recall covers more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets under the brand name Ziac. Testing of reserve samples showed presence of ezetimibe, a drug used for high cholesterol, FDA officials said in a report published online.
The recall level for the drug is Class III, meaning the use or exposure to the product is “not likely to cause adverse health consequences.”
Glenmark Pharmaceuticals Inc., located in Elmwood Park, N.J., is recalling the pills, which are in 2.5 milligram and 6.25 milligram doses.
The FDA says packages affected are:
-
30-count bottles NDC 68462-878-30
-
100-count bottle NDC 68462-878-01
-
500-count bottles NDC 68462-878-05
The affected lot numbers were set to expire beginning in November 2025 through May 2026.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
For the latest news, weather, sports, and streaming video, head to The Hill.
